Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Goodwill (2023 - 2025)

bioAffinity Technologies (BIAF) has disclosed Goodwill for 3 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Goodwill changed 0.0% to $1.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was $1.4 million, a 0.0% change, with the full-year FY2024 number at $1.4 million, changed 0.0% from a year prior.
  • Goodwill was $1.4 million for Q3 2025 at bioAffinity Technologies, roughly flat from $1.4 million in the prior quarter.
  • In the past five years, Goodwill ranged from a high of $1.4 million in Q4 2023 to a low of $1.1 million in Q3 2023.
  • A 3-year average of $1.4 million and a median of $1.4 million in 2023 define the central range for Goodwill.
  • Biggest YoY gain for Goodwill was 22.28% in 2024; the steepest drop was 0.0% in 2024.
  • bioAffinity Technologies' Goodwill stood at $1.4 million in 2023, then changed by 0.0% to $1.4 million in 2024, then changed by 0.0% to $1.4 million in 2025.
  • Per Business Quant, the three most recent readings for BIAF's Goodwill are $1.4 million (Q3 2025), $1.4 million (Q2 2025), and $1.4 million (Q1 2025).